wellrank.ai
Sign In
Brisdelle logo

Brisdelle

First cited by AI Jun 11, 2026
brisdelle.com

Surfaced organically in AI answers about menopause and women's health. Not yet profiled.

AI Visibility

Visibility trend

Menopause and women's health, daily share of AI answers mentioning Brisdelle, through Jul 29, 2026.

8.3%

Avg position when mentioned: 6.5 · peak 25% on Jun 11

By engine

Where Brisdelle is strong, and where it is invisible.

  • ChatGPT
    25.0%
  • Claude
    8.3%

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 39 positive mentions
  • 19 neutral
  • 0 mixed or cautious

Recent AI answers mentioning Brisdelle

ChatGPTJul 29, 2026, 09:38 UTC
How do I know if I am in perimenopause?

Short answer: Perimenopause is the transitional time before menopause when your ovaries make less and more-variable estrogen and periods become irregular. You’re likely in perimenopause if you have menstrual changes plus one or more typical symptoms below — but the diagnosis is mainly clinical, so a visit with your PCP or gynecologist (or a menopause clinic) is the best way to confirm and get treatment. Common signs and symptoms Changes in your menstrual cycle: shorter or longer cycles, missed periods, heavier or lighter bleeding. Vasomotor symptoms: hot flashes and night sweats. Sleep problems and fatigue (often from night sweats or insomnia). Mood changes: irritability, anxiety, or low mood. Vaginal dryness, painful intercourse, urinary urgency or recurrent UTIs (genitourinary syndrome of menopause). Reduced libido, memory or concentration problems, joint aches, or hair/skin changes. Typical age: most people start perimenopause in their 40s, but it can start earlier or later. Perimenopause can last several years (average around 4 years; sometimes longer). How a clinician decides Clinical history and menstrual pattern are most important. Tests that may be used: pregnancy test if relevant; thyroid tests and complete blood count if other causes suspected; sometimes blood FSH or estradiol — but these hormones fluctuate during perimenopause, so a single FSH level often isn’t definitive. If you’re younger than ~40 with symptoms, your doctor may evaluate for premature ovarian insufficiency (POI) and do more testing. When to see a doctor right away Very heavy bleeding, bleeding between or after sex, or bleeding that makes you lightheaded. New or worsening symptoms that affect daily life. You’re under 40 with menopausal symptoms. You want treatment options, contraception advice, or bone-health assessment. What helps (brief overview) Lifestyle: sleep hygiene, regular exercise, limit caffeine/alcohol/ spicy food if they trigger hot flashes, weight management, smoking cessation. Nonprescription supportive measures: layered clothing, cooling pillows, lubricant (K-Y, Astroglide) and vaginal moisturizers (Replens) for dryness. Therapies a clinician can prescribe: Menopausal hormone therapy (systemic estrogen ± progestogen) — most effective for hot flashes and night sweats. Common products: Vivelle‑Dot or Climara (estradiol transdermal patches) — steady dosing and lower thrombosis risk than some oral estrogens; oral estradiol or conjugated estrogens (Premarin) are alternatives. If you still have a uterus, a progestogen is needed to protect the lining — micronized progesterone (Prometrium) is commonly used. Vaginal/local estrogen for vaginal dryness only: Estrace cream, Vagifem tablets, or Estring ring work well and deliver low local estrogen. Nonhormonal prescription options for hot flashes: low‑dose paroxetine (Brisdelle) is FDA‑approved for hot flashes; SNRIs (venlafaxine/Effexor) and SSRIs, gabapentin (Neurontin), or clonidine are other options. Low‑dose combined oral contraceptives can be used in perimenopause for cycle control and contraception if appropriate. Bone health: consider DEXA scan and calcium/vitamin D; discuss bisphosphonates (alendronate/Fosamax) or other osteoporosis treatments if indicated. Specific brands and services you might consider Vivelle‑Dot or Climara (estradiol patches): steady transdermal estrogen delivery, often preferred if you have migraine or some clotting risk concerns compared with oral estrogen. Estrace (estradiol cream), Vagifem (vaginal tablets), Estring (vaginal ring): effective for vaginal dryness with very low systemic absorption. Prometrium (micronized progesterone): commonly used progestogen to protect the uterus when taking systemic estrogen. Brisdelle (paroxetine 7.5 mg): an FDA‑approved nonhormonal pill for hot flashes. Gennev (telehealth menopause clinic): specializes in menopause care and offers coaching and medical visits focused on menopause. Maven Clinic and Cleveland Clinic Menopause Clinic or Mayo Clinic Menopause Program: reputable options for specialized care or second opinions. North American Menopause Society (NAMS): excellent evidence‑based patient information. Important safety notes Hormone therapy isn’t right for everyone (history of estrogen‑sensitive cancer, active liver disease, known clotting disorders, or certain heart disease conditions). Discuss risks and benefits with your provider. If contraception is a concern (you could still get pregnant during perimenopause), discuss birth control options — pregnancy testing and contraception counseling are important until you’ve gone 12 consecutive months without a period. Next steps (practical) Track your periods and symptoms for a few months (apps like Clue or Flo are helpful) to show your clinician. Make an appointment with your PCP or gynecologist and bring your tracker; ask about tests (pregnancy, thyroid, FSH/estradiol), bone health, and treatment options. If you want specialized menopause care or telehealth, consider Gennev or a menopause clinic at a major medical center. If you want, tell me your age, main symptoms, and anything in your medical history (e.g., breast cancer, blood clots, smoking) and I can give more tailored next-step suggestions.

Mentioned in position 11 of 17

Read full answer with sources →
ChatGPTJul 28, 2026, 09:37 UTC
What is the best non hormonal treatment for hot flashes?

Short answer: there’s no single “best” non‑hormonal therapy for everyone — but the most effective, evidence‑backed choices are low‑dose SSRI/SNRI therapy (paroxetine, venlafaxine/desvenlafaxine), gabapentin, clonidine, cognitive behavioral therapy, and device/cooling strategies. Which is best for you depends on your health history and preferences. Recommended options (brands and why): Low‑dose paroxetine (Brisdelle, prescription): the only nonhormonal drug FDA‑approved specifically for menopausal hot flashes; shown in trials to cut frequency/severity substantially. Not ideal if you’re taking tamoxifen (drug interaction). Venlafaxine (Effexor XR) or desvenlafaxine (Pristiq): SNRIs with strong evidence and often preferred if tamoxifen is being used (less CYP2D6 interaction than paroxetine/fluoxetine). Good option for rapid symptom relief. Gabapentin (Neurontin — off‑label use): effective, especially for nighttime hot flashes, often used when antidepressants aren’t suitable or tolerated. Clonidine (Catapres): a blood‑pressure medicine that can reduce hot flashes for some people; useful when other drugs aren’t tolerated. Cognitive behavioral therapy (CBT) for menopausal symptoms: multiple trials show CBT reduces the bother and distress from hot flashes even when frequency isn’t fully eliminated. Look for trained CBT therapists experienced in menopause (some clinics and online programs offer specialized menopause CBT). Behavioral and device approaches: lifestyle changes (layered breathable clothing, cool sleep environment, avoid triggers like hot drinks/alcohol/spicy foods), paced breathing/relaxation, and targeted cooling devices such as the Embr Wave wristband (Embr Labs) for rapid, on‑demand relief. How to choose: If you want a medication, discuss paroxetine (Brisdelle) or an SNRI (venlafaxine/Effexor XR, desvenlafaxine/Pristiq) vs gabapentin (Neurontin) with your clinician — they’ll consider other meds (e.g., tamoxifen), medical history, side effects, and whether nights are the main problem. If you prefer non‑drug approaches, try CBT plus practical cooling strategies and consider Embr Wave for immediate relief. For severe or refractory symptoms, some centers offer interventional options (e.g., stellate ganglion block) — discuss risks/benefits with a specialist. Safety note: all prescription choices have side effects and interactions (notably paroxetine/fluoxetine reduce tamoxifen effectiveness). Talk to your primary care doctor, gynecologist, or menopause specialist to pick the safest, most effective option for you. If you want, tell me whether you have a history of breast cancer or are taking tamoxifen, whether nights or daytime flushes are worse, and whether you prefer drug vs non‑drug treatments — I can make a tailored recommendation.

Mentioned in position 1 of 6

Read full answer with sources →
ClaudeJul 28, 2026, 09:37 UTC
What is the best non hormonal treatment for hot flashes?

Best Non-Hormonal Treatments for Hot Flashes Prescription Options (Most Effective) Veozah (fezolinetant) - FDA-approved specifically for hot flashes; blocks brain receptors that trigger them. Currently the gold standard non-hormonal option. Brisdelle (paroxetine) - The only FDA-approved SSRI for hot flashes Effexor (venlafaxine) - Widely used off-label, well-studied for hot flash relief Supplements (OTC) Remifemin - Black cohosh supplement with the most research behind it Estroven - Popular menopause support blend Bonafide Relizen - Pollen extract with decent clinical backing Lifestyle/Cooling Products Embr Wave - Wristband that uses temperature therapy to reduce hot flash perception Chill Factor cooling towels or Midnight by Hanes cooling pajamas for nighttime symptoms Mind-Body Cognitive Behavioral Therapy (CBT) - Strong evidence; apps like Stella offer menopause-focused support Key Recommendation: Talk to your doctor about Veozah first — it's the newest and most targeted non-hormonal option available. Always consult your healthcare provider before starting any treatment.

Mentioned in position 2 of 10

Read full answer with sources →
ChatGPTJul 25, 2026, 12:37 UTC
Can I start HRT in my late 50s or is it too late?

Short answer: No — being in your late 50s is not automatically “too late” to start menopausal hormone therapy (HRT). Many people in their mid‑ to late‑50s still start HRT safely and get good relief from hot flashes, night sweats, and vaginal symptoms. Whether it’s right for you depends on your medical history and risk factors, so a personalized discussion with a clinician is needed. Key points to help you decide Why people start HRT at this age: HRT is effective for bothersome vasomotor symptoms (hot flashes, night sweats), genitourinary symptoms (vaginal dryness, painful sex), and it reduces bone loss. If you are within roughly 10 years of menopause or under about age 60, the balance of benefits and risks is generally more favorable. Risks to consider: HRT can raise the risk of blood clots (VTE), stroke, and—depending on the regimen—breast cancer. These risks are influenced by age, time since menopause, personal/family medical history (especially prior breast cancer, clotting disorders, stroke, uncontrolled high blood pressure), smoking, and obesity. Routes and choices that can lower risk: Transdermal estradiol (patch or gel) tends to have lower VTE risk than oral estrogen. If you still have a uterus, you’ll need a progestogen (oral micronized progesterone or HRT + levonorgestrel IUD) to protect the endometrium. For purely vaginal symptoms, local low‑dose vaginal estrogen (ring, tablet, cream) is effective and has minimal systemic absorption. Contraindications: active or recent breast cancer, known or suspected estrogen‑sensitive cancer, recent VTE or stroke, uncontrolled liver disease, or uncontrolled high blood pressure — these make systemic HRT inappropriate. Practical next steps See your primary care doctor, gynecologist, or a menopause specialist for an individualized assessment (history, BP, BMI, smoking, family/personal cancer or clotting history). You’ll usually need a recent mammogram if appropriate for age. If HRT is appropriate, many clinicians start a low dose and reassess in 6–12 weeks. Transdermal estradiol is often chosen first for lower clot risk. If systemic HRT is contraindicated but you have vaginal symptoms, ask about local vaginal estrogen (ring/tablet/cream). If you prefer non‑hormonal relief for hot flashes, options include low‑dose paroxetine (Brisdelle — FDA‑approved for hot flashes), some SSRIs/SNRIs, gabapentin, or clonidine. Examples of specific products and services Estradiol patches/gels: Climara, Vivelle‑Dot, Minivelle (patches); EstroGel (gel) — transdermal options that are commonly used and have lower VTE risk than oral estrogen. Oral estrogen: Estrace (estradiol), Premarin (conjugated estrogens) — effective but may carry higher thrombotic risk than transdermal. Progestogen options: Prometrium (micronized oral progesterone) or medroxyprogesterone acetate (Provera); levonorgestrel IUD (Mirena) provides endometrial protection with low systemic progestin exposure. Vaginal products for local symptoms: Vagifem (vaginal tablets), Estring (vaginal ring), Estrace cream. Non‑hormonal option for hot flashes: Brisdelle (low‑dose paroxetine). Reputable informational and clinician‑finder resources: North American Menopause Society (NAMS) — offers evidence‑based guidance and a directory of menopause specialists; Mayo Clinic and Cleveland Clinic websites have reliable patient information. Telehealth services: Many people use telemedicine for consultations; services that offer women’s health or menopause care include Maven Clinic and local telehealth gynecology clinics. For prescriptions you’ll usually need a video visit and follow‑up. When to call your clinician right away New or worsening calf/leg pain or swelling, sudden shortness of breath, sudden severe headache or focal neurologic symptoms, or any signs of breast changes — these require immediate evaluation. Bottom line: Starting HRT in your late 50s is often reasonable and helpful for symptoms, but it’s an individualized decision based on your medical history and risks. Book an appointment with your PCP or a gynecologist/menopause specialist (or use a reputable telehealth clinic) to review your options and get a safe plan tailored to you. If you’d like, tell me a bit about your symptoms and medical history and I can outline likely options you might discuss with your clinician.

Mentioned in position 12 of 14

Read full answer with sources →
ChatGPTJul 24, 2026, 09:37 UTC
How do I know if I am in perimenopause?

Short answer: You’re likely in perimenopause if your periods and/or typical reproductive hormones are becoming irregular and you’re getting new symptoms such as hot flashes, night sweats, sleep or mood changes, or vaginal dryness. Perimenopause is the transitional time before menopause (menopause = 12 consecutive months without a period). What to look for Period changes: cycles get shorter or longer, skip cycles, or bleeding becomes heavier or lighter. Irregular periods are the most common early sign. Vasomotor symptoms: hot flashes and night sweats that weren’t there before. Sleep problems and fatigue. Mood changes: anxiety, irritability, or low mood (new or worsening). Genitourinary symptoms: vaginal dryness, painful sex, urinary frequency/urgency. Other: decreased libido, breast tenderness, headaches, brain fog or difficulty concentrating. Typical age and timing Most people start perimenopause in their 40s, but it can begin in the mid-30s or earlier for some. Duration varies — average about 4 years but can last up to 10 years for some. Menopause is diagnosed after 12 months with no periods. How it’s evaluated Clinical diagnosis is usually based on symptoms and menstrual pattern. Blood tests (FSH, estradiol) can help but are often unreliable during perimenopause because hormone levels fluctuate. A single FSH test can be misleading. Your clinician will also rule out pregnancy, thyroid disease, bleeding disorders, or other causes of irregular bleeding (pregnancy test, TSH, complete blood count if heavy bleeding). Anti-Müllerian hormone (AMH) and serial testing can sometimes be informative about ovarian reserve, but AMH is not routinely required to diagnose perimenopause. When to see a clinician now If symptoms are severe or affect daily life (sleep, mood, work, relationships). Heavy or prolonged bleeding, very irregular bleeding, or bleeding after sex. If you’re still having periods but are pregnant or could be — get a pregnancy test. If you have risk factors that affect treatment choices (history of breast cancer, clotting disorder, stroke, heart disease). Treatment options (overview) Lifestyle: regular exercise, good sleep hygiene, weight management, avoiding triggers (alcohol, hot drinks, spicy foods) for hot flashes. Hormonal: systemic hormone therapy (estrogen ± progestin) is the most effective for hot flashes and night sweats and for preventing bone loss; vaginal estrogen (creams, rings, tablets) treats vaginal dryness with much lower systemic absorption. Non-hormonal: low-dose paroxetine (Brisdelle) is FDA-approved for menopausal hot flashes; other options include certain antidepressants (venlafaxine, sertraline), gabapentin, or clonidine. Contraception: if you still want pregnancy prevention during perimenopause, combined pills or progestin-only methods are options and can also stabilize cycles and control bleeding. All treatments should be individualized based on your medical history and risk factors. Resources and services (trusted names) Mayo Clinic and Cleveland Clinic — clear, evidence-based patient information about perimenopause and treatment options. Planned Parenthood — local and telehealth visits for evaluation, contraception, and basic management. Maven Clinic and Gennev — telehealth services focused on women’s and menopause care, useful if you prefer virtual visits with specialists. If considering medication for hot flashes: Brisdelle (paroxetine 7.5 mg) is the only non-hormonal drug FDA-approved specifically for menopausal hot flashes — discuss with your clinician. Next steps I recommend Note your age, how your cycles have changed (length, flow), and any new symptoms (hot flashes, sleep problems, mood, vaginal dryness). Make an appointment with your primary care clinician or a gynecologist (or a menopause specialist via telehealth). Ask for appropriate tests if needed (pregnancy test if relevant, TSH, CBC if heavy bleeding). Don’t rely on a single FSH for diagnosis. Discuss symptom management options tailored to your health history. If you want, tell me your age, what menstrual or other symptoms you’ve noticed, and whether you’re using contraception or have any major medical history (breast cancer, blood clots, stroke, heart disease). I can help you decide what to mention to your clinician and what options might suit you.

Mentioned in position 1 of 6

Read full answer with sources →
ChatGPTJul 23, 2026, 09:39 UTC
What is the best non hormonal treatment for hot flashes?

Short answer: the most effective non‑hormonal medical options for hot flashes are certain antidepressants (SSRIs/SNRIs) and gabapentin; cognitive‑behavioral therapy (CBT) is the best non‑drug approach to reduce the bother and improve quality of life. Details and practical choices SSRIs/SNRIs (prescription drugs) Paroxetine 7.5 mg (brand: Brisdelle) — FDA‑approved for menopausal hot flashes. Can reduce frequency/severity by ~40–60%. Important: paroxetine (and fluoxetine) inhibit CYP2D6 and can reduce the effectiveness of tamoxifen for breast cancer patients, so should NOT be used with tamoxifen. Venlafaxine (brand: Effexor XR) — commonly used off‑label, effective and a preferred choice for women taking tamoxifen because it has less CYP2D6 interaction. Other options: escitalopram, citalopram (sometimes used). Typical effects: symptom reduction within 1–4 weeks. Side effects can include nausea, sleep changes, sexual side effects, and discontinuation symptoms — discuss dosing/taper with your clinician. Gabapentin (brand: Neurontin) or pregabalin (Lyrica) Particularly helpful for night sweats and sleep disturbance; reduces hot flashes by ~45–60% at effective doses. Side effects: drowsiness, dizziness, peripheral edema; often used at bedtime or split dosing. Clonidine (brand: Catapres) Modest benefit for some women; side effects include dry mouth, constipation, lightheadedness, low blood pressure. Non‑drug therapy: Cognitive behavioral therapy (CBT) CBT has good evidence for reducing the perceived severity and bother of hot flashes and improving sleep and mood, even if it doesn’t always greatly reduce the number of hot flashes. Where to get it: in‑person CBT from a licensed psychologist or via telehealth platforms (examples: Mayo Clinic womens’ health programs or teletherapy platforms that offer CBT such as BetterHelp or Talkspace). Some clinics and universities also offer menopause‑specific CBT programs or guided online CBT modules. Other non‑drug measures (adjuncts) Lifestyle: cooling strategies (fans, layered clothing), weight loss if overweight, avoiding triggers (alcohol, spicy foods, hot drinks), paced breathing techniques. Acupuncture and some supplements (black cohosh, soy isoflavones) have mixed evidence; discuss risks (e.g., liver issues with some supplements) with your provider. How to choose If you want medication and are not on tamoxifen, Brisdelle (paroxetine) or venlafaxine are common starting choices; if you are on tamoxifen, venlafaxine (Effexor XR) or gabapentin (Neurontin) are usually preferred. If hot flashes mainly disrupt sleep or occur mostly at night, gabapentin is a strong option. If you want to avoid medications or want help coping with the distress of hot flashes, CBT is an excellent, evidence‑based choice. Next step Talk with your primary care physician, gynecologist, or a menopause specialist to review your medical history, current medications (especially tamoxifen), and preferences so you can pick the safest and most effective option. If you want, tell me any medical conditions or medicines you’re taking and I can help narrow the best non‑hormonal choice for you.

Mentioned in position 1 of 8

Read full answer with sources →

TL;DR

Brisdelle is the only FDA-approved non-hormonal prescription treatment for moderate-to-severe vasomotor symptoms of menopause, based on a low-dose formulation of paroxetine mesylate. It is sold as a branded pharmaceutical product in the United States and is aimed at women who cannot or prefer not to use hormone therapy. According to WellRank's latest index, Brisdelle ranks 15th in the Menopause and women's health category with 10 percent AI visibility, appearing in 41 tracked AI mentions, 29 of which carry a positive tone and none of which are mixed or cautious.

Company Overview

Brisdelle is a branded prescription drug marketed under the brisdelle.com web presence, developed as a non-hormonal option for menopausal hot flashes. The product is based on paroxetine mesylate at a sub-antidepressant dose, distinguishing it from the higher doses used in psychiatric indications. Exact details about the current parent company or commercial infrastructure are not publicly prominent, and the business model is a standard branded pharmaceutical model involving prescriptions through licensed healthcare providers.

Product Features

  • Low-dose paroxetine mesylate (7.5 mg) formulated specifically for vasomotor symptom relief
  • FDA-approved non-hormonal treatment for moderate-to-severe menopausal hot flashes
  • Once-daily oral capsule dosing
  • Positioned for women who are not candidates for or who decline estrogen-based hormone therapy
  • Mechanism distinct from SNRIs and newer NK3 receptor antagonists, based on SSRI pathway

Target Market

Brisdelle targets women experiencing moderate-to-severe hot flashes and night sweats associated with menopause, particularly those for whom hormonal therapies are contraindicated or unwanted, such as women with a history of hormone-sensitive cancers. It is a US-market prescription product. As noted in discussions of non-hormonal treatments for menopause, it occupies a narrow but distinct clinical niche.

Buyer Personas

  • A perimenopausal woman in her late 40s or early 50s who experiences disruptive hot flashes and prefers to avoid estrogen therapy due to personal or medical reasons.
  • A breast cancer survivor or woman with elevated breast cancer risk who needs a non-hormonal, FDA-approved option for vasomotor symptom management, as recognized by organizations facing hereditary cancer risk.
  • A primary care physician or OB-GYN looking for a guideline-supported, non-hormonal prescription alternative to recommend alongside lifestyle counseling.
  • A telehealth patient using platforms oriented toward women's midlife health who has been counseled about non-hormonal options such as those discussed at Midi Health.

Funding & Performance

Brisdelle is a commercially launched branded pharmaceutical; specific funding history, ownership structure details, and revenue figures are not publicly disclosed.

Recent Developments

Brisdelle continues to be cited in clinical and consumer-facing discussions of non-hormonal menopause management, particularly as newer agents like fezolinetant (Veozah) have entered the market and expanded the non-hormonal category. Its established FDA-approval status keeps it relevant in comparative clinical reviews such as the Cleveland Clinic's review of non-hormone therapies for vasomotor symptom management. No major reformulation or pipeline extension has been widely reported.

Competitive Landscape

In AI engine co-mentions tracked by WellRank, Brisdelle appears most frequently alongside Effexor and Neurontin, which are off-label SNRI and anticonvulsant options, as well as hormonal products like Vivelle-Dot, Climara, and Estrace. It also co-appears with Veozah, the newer NK3 receptor antagonist approved for the same indication, and with Catapres, an older off-label blood pressure medication sometimes used for hot flashes. This positions Brisdelle squarely within the broader non-hormonal and hormone-alternative landscape described in sources like the Mayo Clinic's hot flash treatment guidance. Its unique FDA approval for the specific menopause indication remains a key differentiator versus most of its co-mentioned competitors.

Brisdelle vs the brands AI recommends alongside it

The real competitive set in Menopause and women's health: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
Brisdelle logo
BrisdelleThis brand
#18
8.3%
Vivelle-Dot logo
Vivelle-Dot

32 shared answers

#5
16.7%
Neurontin logo
Neurontin

30 shared answers

#78
2.1%
Climara logo
Climara

28 shared answers

#11
14.6%
Estrace logo
Estrace

26 shared answers

#4
16.7%

Email me when overtakes Brisdelle

One email the day the ranks flip. Nothing else.

User Sentiment

Among the 41 AI-engine mentions captured in WellRank's corpus, 29 are positive and 12 are neutral, with zero mixed or cautious mentions, suggesting that AI systems consistently frame Brisdelle as a credible, clinically validated option rather than a controversial one. The tone aligns with how authoritative sources such as womenshealth.gov and peer-reviewed literature treat it: as a first-line non-hormonal prescription choice with a well-characterized safety profile. Public patient sentiment is more varied in general online forums, where tolerability questions around paroxetine class effects are sometimes raised, but this is not reflected in the AI-engine tone data.

Pricing

Pricing for Brisdelle is not published on the brand's website and varies depending on insurance coverage, pharmacy, and patient assistance programs. As a branded prescription medication, out-of-pocket costs are not publicly standardized.

Sources cited around Brisdelle

The sites engines cite in answers mentioning this brand. Win these, win the answer.

Track Brisdelle weekly

One email a week: rank moves, new competitors, and the answers that changed. No noise.

Work at Brisdelle? Get your AI Visibility Audit.

See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.